BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Jan Vishwas Act Amendment on Pharmacy Act to Take Effect from Dec 31 August 26, 2024 The revised provisions of the Jan Vishwas (Amendment of Provisions) Act, 2023, announced by the Central Government last year, to eliminate harsh penalties from The Pharmacy Act, 1948, will take effect on December 31, 2024.
Health Ministry Bans 156 Fixed Dose Combinations August 23, 2024 The ban includes commonly used medications for cold, fever, and antibacterial and antifungal treatments. The ministry cited these combinations as "irrational" and noted that safer alternatives are available.
India's Pharma & Medical Device Industry Gains Ground in Global Markets August 16, 2024 In 2023, India solidified its position as the third-largest source of pharmaceutical imports to the US, trailing only Ireland and Switzerland
Torrent Pharma Seeks to Raise $3 Bn to Buy KKR’s Stake in JB Chemicals August 14, 2024 Prominent financial institutions such as Barclays Plc, Deutsche Bank AG, and Standard Chartered Plc have been approached to facilitate the funding, according to the sources.
Lord's Mark Microbiotech to Launch Saliva-Based Organ Age Test August 13, 2024 Lord’s Mark Microbiotech, a subsidiary of Lord’s Mark Industries, has launched a new saliva-based test designed to assess the biological age of organs.
NPPA Revises Ceiling Prices of Scheduled Drugs Following DoP Order August 12, 2024 The National Pharmaceutical Pricing Authority (NPPA) has announced upward revisions to the ceiling prices of four scheduled drugs, following directives from the Department of Pharmaceuticals (DoP).
Entod Pharma Onboards Prof Vivek Padgaonkar as an Independent Director August 8, 2024 He holds directorships at Martin & Harris Labs Ltd, Bervin Investment & Leasing Limited, and Juvenor Healthcare.
DoP Approves 7 Applications Under Revamped PTUAS August 7, 2024 The Department of Pharmaceuticals (DoP) has approved seven applications from Micro, Small, and Medium Enterprises (MSMEs) under the revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS).
IIT Mandi Launches BioNEST Center for Biotech & Healthcare Innovation July 31, 2024 The Indian Institute of Technology (IIT) Mandi has launched the BioNEST-IIT Mandi Catalyst Centre, a new initiative to advance biotechnology and healthcare solutions in the Himalayan region.
Akums Drugs IPO Fully Subscribed on Day 1 July 31, 2024 The IPO, which opened on Tuesday with a price band of INR 646-679, saw a subscription rate of 1.37 times by the end of Day 1.
3,053 Drugs Found Substandard & 424 Adulterated in FY 22-23: Govt Reports July 31, 2024 In FY 2022-23, a total of 96,713 drug samples were tested, of which 3,053 were found not to meet standard quality.
Senores Pharmaceuticals Files INR 500 Cr IPO with SEBI July 30, 2024 This IPO comprises a fresh issue of shares worth INR 500 Cr and an offer for sale (OFS) of up to 27 Lakh equity shares by the promoters and other selling shareholders, as outlined in the DRHP.
Healthcare is undergoing a significant transformation, driven by advances in technology that are reshaping how we approach disease prediction, screening, and treatment.
As time progresses, we have witnessed the emergence of new and unknown diseases, making it clear that the pharmaceutical and biotech sectors must continuously adapt.
As healthcare becomes more advanced, there's an increasing demand for innovative technologies to drive improvements in drug discovery, clinical trials, personalized medicine, and more. The intersection of technology and healthcare has revolutionized the way drugs are developed, distributed, and administered.
AI & Machine Learning in Drug Discovery
One of the primary drivers of this evolution is the rise of artificial intelligence (AI) and machine learning (ML), which are dramatically reducing both the time and cost associated with drug discovery. These innovations are helping accelerate the development of new treatments, ensuring that medicines are delivered more effectively and in less time.
AI plays a key role in drug discovery, development, production, and distribution, helping create treatments that are as unique as the patients they serve.
Personalized Medicine & Pharma Innovations
As personalized medicine becomes the focus of modern healthcare, researchers are diving deeper into tailoring treatments to individual patients, moving away from the era of one-size-fits-all approaches. Personalized and precision medicine is a major trend in the industry. Genomic data is being integrated into pharma to develop better-targeted drugs, offering patients more effective treatments that are specifically designed for their individual needs.
The pharmaceutical and biotech industries are also embracing digital therapeutics, where technology is used to manage medical conditions and diseases through digital platforms.
Many biotech companies are now integrating cutting-edge technologiesin gene editing to develop new therapies aimed at treating a range of genetic disorders. These innovations are transforming the healthcare landscape and making previously unimaginable treatments a reality.
Digital Tools & Data Analytics
In terms of pharmaceutical innovations, digital tools, the Internet of Things (IoT), blockchain, and data analytics are all playing an important role in improving transparency, efficiency, and security within pharma supply chains. AI is optimizing logistics, reducing counterfeiting, and ensuring that drug quality is maintained throughout the distribution process.
Telemedicine & Digital Health Platforms
With the increasing role of digital platforms, pharmacies have evolved beyond traditional drug stores; now, online platforms are the main point of contact for patients seeking medications. This has resulted in a growing intersection between telemedicine and pharma, where medications are often prescribed based on digital consultations or AI-driven diagnostics.
This shift to digital health platforms is providing better access to biotech solutions, particularly in underserved areas where traditional healthcare infrastructure might be lacking. These platforms are making it easier for patients to access treatments and for healthcare providers to prescribe and manage them more effectively.
Transforming Clinical Trials with Digital Tech
The way clinical trials are conducted is also transforming thanks to digital technologies! Wearables and mobile apps are being used to collect real-time data from patients, allowing for more accurate monitoring of drug efficacy and patient health.
Virtual clinical trials, where patients can participate remotely, are making trials more accessible and efficient. This technology is not only streamlining the process but also broadening the scope of trials to include a wider range of participants.
Investment in PharmaTech
The rise of pharma-tech is driving increased investment in the sector. Venture capital is increasingly focusing on startups that integrate AI, robotics, and data analytics into biotech and pharmaceutical processes. This influx of capital is accelerating innovation and helping bring new therapies to market faster.
Technology is significantly shaping the future of the pharmaceutical and biotech sectors. From personalized medicine to digital therapeutics and virtual clinical trials, the ongoing evolution is making healthcare more efficient, accessible, and tailored to individual needs. As investments continue to pour into pharma-tech, we can expect even more breakthroughs and innovations that will continue to improve patient care around the world.
